Presbia PLC (NASDAQ: LENS) and Entellus Medical (NASDAQ:ENTL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitabiliy and risk.

Analyst Ratings

This is a summary of current ratings for Presbia PLC and Entellus Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Presbia PLC 0 0 3 0 3.00
Entellus Medical 1 2 4 0 2.43

Presbia PLC currently has a consensus price target of $12.00, indicating a potential upside of 280.95%. Entellus Medical has a consensus price target of $22.00, indicating a potential upside of 54.71%. Given Presbia PLC’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Presbia PLC is more favorable than Entellus Medical.

Risk & Volatility

Presbia PLC has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, Entellus Medical has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500.

Institutional and Insider Ownership

19.6% of Presbia PLC shares are owned by institutional investors. Comparatively, 75.8% of Entellus Medical shares are owned by institutional investors. 71.7% of Presbia PLC shares are owned by company insiders. Comparatively, 9.1% of Entellus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Presbia PLC and Entellus Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Presbia PLC -32,457.45% -132.09% -113.64%
Entellus Medical -39.02% -60.56% -35.90%

Earnings and Valuation

This table compares Presbia PLC and Entellus Medical’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Presbia PLC $16,000.00 3,338.21 -$16.18 million N/A N/A
Entellus Medical $77.39 million 4.03 -$25.43 million ($1.56) -9.12

Presbia PLC has higher revenue, but lower earnings than Entellus Medical.

About Presbia PLC

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

About Entellus Medical

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company’s XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.